Optimizing Screening Intervals for At-Risk Relatives of Dilated Cardiomyopathy Carrying a TTNtv

BACKGROUND: Cardiomyopathy guidelines recommend routine screening of at-risk relatives with dilated cardiomyopathy (DCM). Titin-truncating variants are the most prevalent cause. However, the diagnostic yield of screening is low. Risk-based stratification could optimize screening intervals and resource allocation. This study aims to develop a safe, evidence-based gene-specific longitudinal screening algorithm for DCM development. METHODS: We included likely pathogenic/pathogenic titin-truncating variant relatives from 7 centers who underwent cardiac screening. Relatives were stratified based on their baseline clinical phenotype: genotype-positive/phenotype-negative (no left ventricular dysfunction and dilatation) or partial DCM (ie, fulfilling only 1 criterion). DCM development predictors were identified based on follow-up data. Risk profiles were established and used to develop a multistate model to create a longitudinal screening algorithm to safely and effectively monitor titin-truncating variant relatives. RESULTS: Among 413 relatives, follow-up data were available in 301 relatives (median follow-up 5.7 years), of whom 24.6% developed left ventricular dysfunction or dilatation and 17.3% developed DCM. In total, 16 relatives (5.3%) experienced a major adverse cardiac event after DCM diagnosis. Based on the identified risk factors, age ≥30 years, male sex, and partial DCM, 3 distinct profiles were established: (1) relatives with partial DCM, (2) females ≥30 years and males, and (3) female relatives <30 years. A screening algorithm was developed, recommending intervals of 1, 3, and 5 years, optimizing the balance between safety and effectiveness. CONCLUSIONS: An evidence-based genotype-specific longitudinal screening algorithm that integrates age, sex, and echocardiographic measurements may improve patient care and improve efficiency of clinical resource allocation.

Authors

Institutions

Publication Details

Journal
Circulation Heart Failure
Published
2026-09-21
DOI
https://doi.org/10.1161/circheartfailure.125.013822
Primary Topic
Cardiomyopathy and Myosin Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Optimizing Screening Intervals for At-Risk Relatives of Dilated Cardiomyopathy Carrying a TTNtv

Job A.J. Verdonschot, Alex Hørby Christensen, Christoffer Rasmus Vissing, Daria R. Kramarenko et al.
Circulation Heart Failure
Cardiomyopathy and Myosin Studies
article

Optimizing Screening Intervals for At-Risk Relatives of Dilated Cardiomyopathy Carrying a TTNtv

Job A.J. Verdonschot, Alex Hørby Christensen, Christoffer Rasmus Vissing, Daria R. Kramarenko, Renée Johnson, Sophie L.V.M. Stroeks, Gianfranco Sinagra, Ahmad S. Amin, Fernándo Domínguez, Henning Bundgaard, Max F.G.H.M. Venner, Steven A. Muller, Marco Merlo, Matteo Dal Ferro, Pablo García‐Pavía, Diane Fatkin, Eva Del Mestre, Alessia Paldino, Anneline S.J.M. te Riele, Guilielmus H.J.M. Ellenbroek, Nina J Beelen, Clea González-Maniega
article en

Abstract

BACKGROUND: Cardiomyopathy guidelines recommend routine screening of at-risk relatives with dilated cardiomyopathy (DCM). Titin-truncating variants are the most prevalent cause. However, the diagnostic yield of screening is low. Risk-based stratification could optimize screening intervals and resource allocation. This study aims to develop a safe, evidence-based gene-specific longitudinal screening algorithm for DCM development. METHODS: We included likely pathogenic/pathogenic titin-truncating variant relatives from 7 centers who underwent cardiac screening. Relatives were stratified based on their baseline clinical phenotype: genotype-positive/phenotype-negative (no left ventricular dysfunction and dilatation) or partial DCM (ie, fulfilling only 1 criterion). DCM development predictors were identified based on follow-up data. Risk profiles were established and used to develop a multistate model to create a longitudinal screening algorithm to safely and effectively monitor titin-truncating variant relatives. RESULTS: Among 413 relatives, follow-up data were available in 301 relatives (median follow-up 5.7 years), of whom 24.6% developed left ventricular dysfunction or dilatation and 17.3% developed DCM. In total, 16 relatives (5.3%) experienced a major adverse cardiac event after DCM diagnosis. Based on the identified risk factors, age ≥30 years, male sex, and partial DCM, 3 distinct profiles were established: (1) relatives with partial DCM, (2) females ≥30 years and males, and (3) female relatives <30 years. A screening algorithm was developed, recommending intervals of 1, 3, and 5 years, optimizing the balance between safety and effectiveness. CONCLUSIONS: An evidence-based genotype-specific longitudinal screening algorithm that integrates age, sex, and echocardiographic measurements may improve patient care and improve efficiency of clinical resource allocation.

Circulation Heart Failure
Utrecht University (NL), Maastricht University Medical Centre (NL), Copenhagen University Hospital (DK), Gentofte Hospital (DK), Rigshospitalet (DK), University Medical Center Utrecht (NL), UNSW Sydney (AU), Maastricht University (NL), St Vincent's Hospital Sydney (AU), Hospital Universitario Puerta de Hierro Majadahonda (ES), Netherlands Heart Institute (NL), ERN GUARD-Heart (NL), Amsterdam University Medical Centers (NL), Azienda Sanitaria Universitaria Integrata di Trieste (IT)
Decent work and economic growth
Openalex Percentile: Top 11%
Cardiomyopathy and Myosin Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.